ArticleEuropean stroke journal2026
ASPECTS as a surrogate marker of core-perfusion mismatch in late-window large vessel occlusion stroke.
Article in European stroke journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn acute stroke due to a large vessel occlusion (AIS-LVO), identifying a core-perfusion mismatch guides reperfusion therapy in extended time window, but perfusion imaging is not universally available. We investigated whether the Alberta Stroke Program Early CT Score (ASPECTS) is associated with core-perfusion mismatch and could serve as a surrogate imaging marker. PATIENTS AND
methodsWe retrospectively analysed a large multicentre international unselected cohort of consecutive AIS-LVO patients imaged between 4.5 and 24 h from last time seen well, with baseline CT- or MR-perfusion imaging. Core-perfusion mismatch was defined as a mismatch volume ≥ 15 mL and a mismatch ratio ≥ 1.8 using automated software. CT and MRI cohorts were analysed separately.
resultsAmong 531 included patients, 182 underwent CT and 349 MRI. Core-perfusion mismatch was present in 86% of CT patients and 62% of MRI patients. Alberta Stroke Program Early CT Score was strongly associated with mismatch in both cohorts (P < .001). In the MRI cohort, ASPECTS predicted mismatch with an area under the receiver operating characteristic curve (AUC) of 0.843 (95% CI, 0.797-0.890), with an optimal cutoff ≥ 6, yielding sensitivity 0.87, specificity 0.72, positive predictive value (PPV) 0.84 and negative predictive value (NPV) 0.77. In the CT cohort, the AUC was 0.801 (95% CI, 0.698-0.904), with an optimal cutoff ≥ 7, yielding sensitivity 0.74, specificity 0.81, PPV 0.96 and NPV 0.34.
conclusionThe high PPV of ASPECTS ≥ 6 on MRI and ASPECTS ≥ 7 on CT supports their potential use as pragmatic enrichment criteria for patient selection in future late-window AIS-LVO trials, when perfusion imaging is unavailable, as surrogate markers of salvageable tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.